Loading
Life sciences · Journal article
Journal of Ayurveda and Integrated Medical Sciences · July 21, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that assembles claims from traditional AYUSH systems and emerging evidence for psychiatric disorders, including RCTs, animal studies, and classical references. The source does not perform systematic appraisal, meta-analysis, or quantified synthesis, and does not report specific effect sizes, confidence intervals, or statistical comparisons from the primary studies it cites, making it an exploratory synthesis rather than a conclusive evidence statement.
Narrative review. Literature addressing AYUSH interventions for common psychiatric disorders (depression, anxiety, schizophrenia, cognitive decline); classical and contemporary sources.. Intervention: AYUSH modalities including Ayurveda (Withania somnifera, Bacopa monnieri, Panchakarma/Shirodhara), Yoga-based interventions, Unani formulations (Majun Brahmi, Tiryaq Arba), and Siddha preparations.. Compared with: Standard pharmacotherapy and psychotherapy reported in cited studies; no direct head-to-head comparison conducted within this review.. Global scope; database search spanning multiple languages and traditions..
Withania somnifera (Ashwagandha) demonstrated anxiolytic and anti-depressant effects comparable to standard pharmacotherapy in multiple RCTs Bacopa monnieri (Brahmi) improved memory consolidation, attention, and cognitive processing Yoga-based interventions reduced depression and anxiety scores (HAM-D, GAD-7) with effect sizes comparable to psychotherapy
Withania somnifera (Ashwagandha) demonstrated anxiolytic and anti-depressant effects comparable to standard pharmacotherapy in multiple RCTs
This review suggests that AYUSH modalities may offer cost-effective and culturally acceptable options for psychiatric care, but the evidence presented is not sufficiently rigorous or integrated to guide clinical practice changes. Clinicians should await well-designed multicentric RCTs with prespecified primary endpoints and standardized outcome measures before incorporating these modalities into mainstream care.
A narrative review synthesizing heterogeneous evidence (RCTs, preclinical studies, classical texts) across multiple AYUSH disciplines without systematic methodology, meta-analysis, or quantitative synthesis; raises questions about integration rather than answering them with definitive clinical evidence.
As stated by the source record.
Quoted from the source exactly as published.
This review suggests that AYUSH modalities may offer cost-effective and culturally acceptable options for psychiatric care, but the evidence presented is not sufficiently rigorous or integrated to guide clinical practice changes. Clinicians should await well-designed multicentric RCTs with prespecified primary endpoints and standardized outcome measures before incorporating these modalities into mainstream care.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Mental health disorders represent one of the most pressing public health challenges of the 21st century, affecting more than one billion individuals globally. Despite remarkable pharmacological advances, conventional psychiatric care continues to face significant limitations including adverse drug effects, treatment resistance, and limited accessibility in low- and middle-income countries. AYUSH systems — encompassing Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy — offer time-tested, holistic frameworks for understanding and managing psychiatric conditions that are gaining renewed scientific scrutiny. Objective: To systematically review the conceptual frameworks, therapeutic modalities, and emerging clinical evidence supporting the role of AYUSH disciplines in the management of common psychiatric disorders, including depression, anxiety, schizophrenia, and cognitive decline. Methods: A comprehensive narrative review was conducted by searching PubMed, Scopus, Google Scholar, and DHARA (Digital Helpline for Ayurveda Research Articles) databases from inception to March 2026. Peer-reviewed clinical trials, randomized controlled trials (RCTs), systematic reviews, and classical textual references were included. Search terms included "AYUSH psychiatry", "Ayurveda mental health", "Medhya Rasayana", "Yoga anxiety", "Unani neuropsychiatric", and "Siddha mental disorders." Results: Evidence supports the efficacy of several AYUSH interventions: Withania somnifera (Ashwagandha) demonstrated significant anxiolytic and anti-depressant effects comparable to standard pharmacotherapy in multiple RCTs. Bacopa monnieri (Brahmi) improved memory consolidation, attention, and cognitive processing. Yoga-based interventions reduced depression and anxiety scores (HAM-D, GAD-7) with effect sizes comparable to psychotherapy. Panchakarma procedures, particularly Shirodhara, showed measurable reductions in cortisol and improvements in sleep quality and autonomic balance. Unani formulations such as Majun Brahmi and Tiryaq Arba demonstrated neuroprotective properties in preclinical studies. Siddha preparations enriched with heavy metal-mineral compounds (after Shodhana purification) exhibited anti-oxidant and neurotrophic effects in animal models. Conclusion: AYUSH systems offer scientifically credible, cost-effective, and culturally acceptable therapeutic options for psychiatric care. Integrating these validated modalities within the mainstream mental healthcare framework — with rigorous pharmacovigilance, standardized dosing protocols, and ethical oversight — holds transformative potential. Well-designed multicentric RCTs and translational research are urgently needed to consolidate the evidence base.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.